<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncotarget</journal-id><journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">ImpactJ</journal-id><journal-title-group><journal-title>Oncotarget</journal-title></journal-title-group><issn pub-type="epub">1949-2553</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5650457</article-id><article-id pub-id-type="publisher-id">18497</article-id><article-id pub-id-type="doi">10.18632/oncotarget.18497</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Carrasco-Avino</surname><given-names>Gonzalo</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Riquelme</surname><given-names>Ismael</given-names></name><xref ref-type="aff" rid="A3"><sup>3</sup></xref><xref ref-type="aff" rid="A4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Padilla</surname><given-names>Oslando</given-names></name><xref ref-type="aff" rid="A5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Villaseca</surname><given-names>Miguel</given-names></name><xref ref-type="aff" rid="A4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aguayo</surname><given-names>Francisco R.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Corvalan</surname><given-names>Alejandro H.</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref><xref ref-type="aff" rid="A7"><sup>7</sup></xref><xref ref-type="aff" rid="A8"><sup>8</sup></xref></contrib><aff id="A1"><sup>1</sup> Advanced Center for Chronic Diseases (ACCDIS), Pontificia Universidad Catolica de Chile, Santiago, Chile</aff><aff id="A2"><sup>2</sup> Department of Pathology, Faculty of Medicine, Universidad de Chile, Santiago, Chile</aff><aff id="A3"><sup>3</sup> Scientific and Technological Bioresource Nucleus (BIOREN), Universidad de la Frontera, Temuco, Chile</aff><aff id="A4"><sup>4</sup> Department of Pathology, Universidad de la Frontera, Temuco, Chile</aff><aff id="A5"><sup>5</sup> Department of Public Health, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile</aff><aff id="A6"><sup>6</sup> Department of Basic and Clinical Oncology, Faculty of Medicine, Universidad de Chile, Santiago, Chile</aff><aff id="A7"><sup>7</sup> UC-Center for Investigational Oncology (CITO), Pontificia Universidad Catolica de Chile, Santiago, Chile</aff><aff id="A8"><sup>8</sup> Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile</aff></contrib-group><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Alejandro H. Corvalan, <email>corvalan@med.puc.cl</email></corresp></author-notes><pub-date pub-type="collection"><day>26</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>15</day><month>6</month><year>2017</year></pub-date><volume>8</volume><issue>43</issue><fpage>75687</fpage><lpage>75698</lpage><history><date date-type="received"><day>20</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>29</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2017 Carrasco-Avino et al.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>Epstein-Barr virus-associated gastric carcinoma shows a higher prevalence in the Americas than Asia. We summarize all studies of Epstein Barr virus-associated gastric carcinoma in the Americas, focusing on host characteristics, environmental associations and phylogeographic diversity of Epstein-Barr virus strains. In the Americas, the prevalence of Epstein Barr virus-associated gastric carcinoma is 11.4%, more frequent in males and portray predominantly diffuse-type histology. EBERs, EBNAs, BARTs and LMP are the highest expressed genes; their variations in healthy individuals may explain the phylogeographic diversity of Epstein-Barr virus across the region. Gastric cancer cases harbor exclusively the western genotype (subtype D and kept Xho I site), suggesting a disrupted co-evolution between the pathogen and its host. Epstein-Barr virus-associated gastric carcinoma molecular subtype cases from The Cancer Genome Atlas display PIK3CA gene mutations, amplification of JAK2, PD-L1 and PD-L2 and CpG island methylator phenotype, leading to more extensive methylation of host and viral genomes than any other subtypes from the study. Environmental conditions include negative- and positive- associations with being firstborn child and smoking, respectively. A marginal association with H. pylori has also been reported. Lymphoepithelioma-like carcinoma is associated with Epstein Barr virus in 80%&#x02013;86% of cases, most of which have been included as part of Epstein Barr virus-associated gastric carcinoma series (prevalence 1.1%&#x02013;7.6%). Whether these cases represent a variant of Epstein-Barr virus-associated gastric carcinoma is discussed. We propose novel research strategies to solve the conundrum of the high prevalence of Epstein-Barr virus-associated gastric carcinoma in the Americas.</p></abstract><kwd-group><kwd>gastric cancer</kwd><kwd>Epstein-Barr virus</kwd><kwd>americas</kwd><kwd>molecular classification</kwd><kwd>phylogeographic diversity</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>INTRODUCTION</title><p>Gastric cancer is the fifth most common malignancy and the third leading cause of cancer death in both sexes worldwide, accounting for 951,000 new cases and 723,000 deaths in 2012 [<xref rid="R1" ref-type="bibr">1</xref>]. As with other infection-related cancers, an increasing proportion of gastric cancer falls on low- and middle-income countries including the Americas-particularly, Central and South America [<xref rid="R2" ref-type="bibr">2</xref>]. The highest prevalence rates have been observed in countries from the pacific coast such as Chile, Costa Rica, Colombia, and Ecuador (i.e. &#x0003e; 20 cases per 100 000 men); whereas the lowest rates have been observed in the U.S., Canada, Argentina, Cuba, and Puerto Rico (&#x0003c; 4/100000) [<xref rid="R2" ref-type="bibr">2</xref>]. Due to the growth and aging of the population, gastric cancer is expected to escalate from the fifteenth to the tenth cause of death in all-cause mortality within the region in the next 15 years [<xref rid="R3" ref-type="bibr">3</xref>].</p><p>In this scenario, novel molecular classifications and meta-analyses have identified Epstein-Barr virus (EBV) as a distinct etiological agent for gastric cancer [<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R7" ref-type="bibr">7</xref>]. A striking feature of EBV-associated gastric carcinoma (EBVaGC) is the high prevalence observed in the Americas as compared with Asia (OR: 1.7, 95% CI:1.1&#x02013;2.7) [<xref rid="R7" ref-type="bibr">7</xref>]. The main purposes of this review are to describe the clinical, molecular and environmental characteristics of EBVaGC in the Americas, and to propose novel research strategies for the exploration of this conundrum.</p><sec id="s1_1"><title>EBV-associated gastric carcinoma in the <bold>Americas</bold></title><p>EBVaGC in the Americas was first reported by Shibata and coworkers [<xref rid="R8" ref-type="bibr">8</xref>]. These authors identified 22 of 138 (16%) EBV-positive cases in U.S. GC cases by <italic>in-situ</italic> hybridization of EBV-encoded small RNAs (EBERs) in tumor samples. In positive cases, EBERs were expressed exclusively in gastric tumor cells. No EBV sequences were detected in the surrounding lymphocytes or precancerous lesions, such as chronic gastritis or intestinal metaplasia. In addition, EBVaGCs were more frequently observed in males than females (<italic>p</italic> = 0.007). Subsequent studies by Gulley and coworkers [<xref rid="R9" ref-type="bibr">9</xref>] and Vo and coworkers [<xref rid="R10" ref-type="bibr">10</xref>], identified 11 of 95 (12%) and 9 of 43 (20%) EBV-positive GC cases, respectively, in Mexican descendants living in the U.S. However, only Vo et al. [<xref rid="R10" ref-type="bibr">10</xref>] confirmed male predominance (<italic>p</italic> = 0.01). Later, Herrera-Goepfert et al. [<xref rid="R11" ref-type="bibr">11</xref>] identified 24 of 330 (7.3%) EBV-positive cases in Mexico City. In this series, no male predominance was confirmed. Interestingly, all cases were of diffuse-type histology. In Colombia, Carrascal et al., [<xref rid="R12" ref-type="bibr">12</xref>] examined 178 consecutive gastric carcinoma cases identifying 23 (13%) cases of EBVaGCs. In this study, EBVaGCs were most often detected in males (<italic>p</italic> = 0.004), and located predominantly on the non-antrum stomach (<italic>p =</italic> 0.009). Koriyama et al., [<xref rid="R13" ref-type="bibr">13</xref>] examined 151 cases from Brazil, detecting 11.2% of EBVaGC. Although EBVaGC was most frequent among males (<italic>p</italic> = 0.047), Lopes and coworkers [<xref rid="R14" ref-type="bibr">14</xref>] did not confirm this finding in a posterior study. Another series consisting of 254 gastric cancer cases from Japanese descendants living in Peru were evaluated by Yoshiwara et al., [<xref rid="R15" ref-type="bibr">15</xref>], identifying only 3.9% EBVaGC (10 cases). In this series, no evident predominance by gender or histological subtype were detected. Finally, in Chile, Corvalan and coworkers [<xref rid="R16" ref-type="bibr">16</xref>] detected 31 of 185 (16.8%) EBV-positive gastric cancer cases. In this series, predominance of diffuse-type histology (<italic>p &#x0003c;</italic> 0.001) and non-antrum location (<italic>p =</italic> 0.01) were the most significant findings. No reports of EBVaGC have been described in other American countries. A consolidated overview of EBVaGC in the Americas is shown in Table <xref ref-type="table" rid="T1">1</xref>. The meta-analytic estimated prevalence of EBV positivity in the region was 11.49% (95% CI = 8.46 to 15.43), with high heterogeneity among studies (I<sup>2</sup> = 73.3%; <italic>p &#x0003c;</italic> 0.001). Interestingly, heterogeneity for predominant sex, location and histology was low (I2=16.5% [<italic>p =</italic> 0.35]; 0% [<italic>p =</italic> 0.68] and 33.7% [<italic>p =</italic> 0.16], respectively). Univariate analysis shows male predominance (<italic>p &#x0003c;</italic> 0.001), non-antrum location (<italic>p &#x0003c;</italic> 0.001) and diffuse-type histology (<italic>p &#x0003c;</italic> 0.001) as the most significant features of EBVaGC in the Americas. Odds-ratio estimated for male predominance and diffuse histology were 2.19 (95% CI: 1.35&#x02013;3.56) and 2.16 (95% CI: 1.33&#x02013;3.49), respectively (see Figure <xref ref-type="fig" rid="F1">1</xref> and Figure <xref ref-type="fig" rid="F2">2</xref>).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>EBV-associated gastric cancer in Latin America</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1"/><th colspan="3" align="center" valign="middle" rowspan="1">Sex</th><th colspan="3" align="center" valign="middle" rowspan="1">Histology</th><th colspan="3" align="center" valign="middle" rowspan="1">Location</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Authors</th><th align="center" valign="middle" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" rowspan="1" colspan="1">Frequency</th><th align="center" valign="middle" rowspan="1" colspan="1">Male</th><th align="center" valign="middle" rowspan="1" colspan="1">Female</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic> value</th><th align="center" valign="middle" rowspan="1" colspan="1">Intestinal</th><th align="center" valign="middle" rowspan="1" colspan="1">Diffuse</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic> value</th><th align="center" valign="middle" rowspan="1" colspan="1">Antrum</th><th align="center" valign="middle" rowspan="1" colspan="1">Non-antrum</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Shibata et al. (1992)</td><td align="center" valign="middle" rowspan="1" colspan="1">U.S.</td><td align="center" valign="middle" rowspan="1" colspan="1">22/138 (16%)</td><td align="center" valign="middle" rowspan="1" colspan="1">21/99</td><td align="center" valign="middle" rowspan="1" colspan="1">1/39</td><td align="center" valign="middle" rowspan="1" colspan="1">0.007049</td><td align="center" valign="middle" rowspan="1" colspan="1">15/95</td><td align="center" valign="middle" rowspan="1" colspan="1">7/43</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Vo et al. (2002)</td><td align="center" valign="middle" rowspan="1" colspan="1">Mexican descendants in the U.S.</td><td align="center" valign="middle" rowspan="1" colspan="1">9/43 (20.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">9/32</td><td align="center" valign="middle" rowspan="1" colspan="1">0/11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.012667</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Gulley et al. (1996)</td><td align="center" valign="middle" rowspan="1" colspan="1">Mexican descendants in the U.S.</td><td align="center" valign="middle" rowspan="1" colspan="1">11/95 (12%)</td><td align="center" valign="middle" rowspan="1" colspan="1">9/50</td><td align="center" valign="middle" rowspan="1" colspan="1">2/33</td><td align="center" valign="middle" rowspan="1" colspan="1">0.116414</td><td align="center" valign="middle" rowspan="1" colspan="1">4/47</td><td align="center" valign="middle" rowspan="1" colspan="1">7/37</td><td align="center" valign="middle" rowspan="1" colspan="1">0.160373</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Herrera-Goepfert et al. (2005)</td><td align="center" valign="middle" rowspan="1" colspan="1">Mexico</td><td align="center" valign="middle" rowspan="1" colspan="1">24/330 (7.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">13/173</td><td align="center" valign="middle" rowspan="1" colspan="1">11/157</td><td align="center" valign="middle" rowspan="1" colspan="1">0.859116</td><td align="center" valign="middle" rowspan="1" colspan="1">4/141</td><td align="center" valign="middle" rowspan="1" colspan="1">20/189</td><td align="center" valign="middle" rowspan="1" colspan="1">0.007012</td><td align="center" valign="middle" rowspan="1" colspan="1">16/192</td><td align="center" valign="middle" rowspan="1" colspan="1">8/156</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24061</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Carrascal et al .2003</td><td align="center" valign="middle" rowspan="1" colspan="1">Colombia</td><td align="center" valign="middle" rowspan="1" colspan="1">23/178 (13%)</td><td align="center" valign="middle" rowspan="1" colspan="1">19/108</td><td align="center" valign="middle" rowspan="1" colspan="1">4/69</td><td align="center" valign="middle" rowspan="1" colspan="1">0.022833</td><td align="center" valign="middle" rowspan="1" colspan="1">11/91</td><td align="center" valign="middle" rowspan="1" colspan="1">12/86</td><td align="center" valign="middle" rowspan="1" colspan="1">0.712179</td><td align="center" valign="middle" rowspan="1" colspan="1">14/67</td><td align="center" valign="middle" rowspan="1" colspan="1">6/81</td><td align="center" valign="middle" rowspan="1" colspan="1">0.016888</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Koriyama et al. (2001)</td><td align="center" valign="middle" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" rowspan="1" colspan="1">17/151 (11.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">15/102</td><td align="center" valign="middle" rowspan="1" colspan="1">2/49</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05314</td><td align="center" valign="middle" rowspan="1" colspan="1">6/66</td><td align="center" valign="middle" rowspan="1" colspan="1">11/84</td><td align="center" valign="middle" rowspan="1" colspan="1">0.442513</td><td align="center" valign="middle" rowspan="1" colspan="1">3/11</td><td align="center" valign="middle" rowspan="1" colspan="1">8/95</td><td align="center" valign="middle" rowspan="1" colspan="1">0.052271</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Lopes et al. (2004)</td><td align="center" valign="middle" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" rowspan="1" colspan="1">6/53 (11.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5/30</td><td align="center" valign="middle" rowspan="1" colspan="1">1/17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.287087</td><td align="center" valign="middle" rowspan="1" colspan="1">1/27</td><td align="center" valign="middle" rowspan="1" colspan="1">5/18</td><td align="center" valign="middle" rowspan="1" colspan="1">0.019945</td><td align="center" valign="middle" rowspan="1" colspan="1">1/6</td><td align="center" valign="middle" rowspan="1" colspan="1">2/22</td><td align="center" valign="middle" rowspan="1" colspan="1">0.594853</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Yoshiwara et al. (2005)</td><td align="center" valign="middle" rowspan="1" colspan="1">Peru</td><td align="center" valign="middle" rowspan="1" colspan="1">10/254 (3.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5/115</td><td align="center" valign="middle" rowspan="1" colspan="1">5/123</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">4/127</td><td align="center" valign="middle" rowspan="1" colspan="1">6/117</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Corval&#x000e1;n et al. (2001)</td><td align="center" valign="middle" rowspan="1" colspan="1">Chile</td><td align="center" valign="middle" rowspan="1" colspan="1">31/185 (16.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">23/121</td><td align="center" valign="middle" rowspan="1" colspan="1">8/69</td><td align="center" valign="middle" rowspan="1" colspan="1">0.183499</td><td align="center" valign="middle" rowspan="1" colspan="1">10/114</td><td align="center" valign="middle" rowspan="1" colspan="1">21/71</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">25/119</td><td align="center" valign="middle" rowspan="1" colspan="1">4/63</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01015</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Consolidate</td><td align="center" valign="middle" rowspan="1" colspan="1">153/1427 (10.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">119/830</td><td align="center" valign="middle" rowspan="1" colspan="1">34/567</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">40/613</td><td align="center" valign="middle" rowspan="1" colspan="1">82/602</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">59/395</td><td align="center" valign="middle" rowspan="1" colspan="1">28/417</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr></tbody></table><table-wrap-foot><p>The meta-analytic estimated prevalence of EBV positivity in the region was 11.49% (95% CI = 8.46 to 15.43).</p><p>Meta-analyses was performed by a random-effects model with the Inverse variance method, using the DerSimonian-Laird estimator, an logit transformation and the Clopper-Pearson confidence interval for individual studies.</p><p>I2 = 73.3% (<italic>p</italic> &#x0003c; 0.001).</p></table-wrap-foot></table-wrap><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Estimated odds ratio (95% CI) for male predominance of EBV-associated gastric cancer in the Americas</title><p>Meta-analyses were performed by a random-effects model with the Inverse variance method, using the DerSimonian-Laird estimator, a logit transformation and the Clopper-Pearson confidence interval for individual studies. The results are shown in a log-scale.</p></caption><graphic xlink:href="oncotarget-08-75687-g001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Estimated odds ratio (95% CI) for diffuse-type histology of EBV-associated gastric carcinoma in the Americas</title><p>Meta-analyses were performed by a random-effects model with the Inverse variance method, using the DerSimonian-Laird estimator, a logit transformation and the Clopper-Pearson confidence interval for individual studies. The results are shown in a log-scale.</p></caption><graphic xlink:href="oncotarget-08-75687-g002"/></fig></sec><sec id="s1_2"><title>Role of viral factors in the pathogenesis of EBV-associated gastric carcinoma</title><sec id="s1_2_1"><title>Overview of viral machinery of EBV</title><p>EBV is a 175Kbp double-stranded lineal DNA virus that belongs to the gamma herpesvirus family [<xref rid="R17" ref-type="bibr">17</xref>]. The main feature of these viruses is the establishment of persistent latent infections and the possibility of viral reactivation under determined conditions. Thus, the virus persists throughout life without any possibility of clearance [<xref rid="R17" ref-type="bibr">17</xref>]. The sequence of events leading to a latent infection are: i) virus entry to cells that express the CD21 receptor, ii) virus transportation to the nucleus, iii) genome circularization and chromatinization, iv) transcription of latency-associated genes and v) repression of lytic cycle genes [<xref rid="R18" ref-type="bibr">18</xref>]. In the neoplastic process, the virus remains in a latent stage in every tumor cell, repressing the expression of genes involved in viral replication. However, virus integration into the host genome almost never occurs, and the EBV genome is always found in an episomal form within the cell nucleus. However, there is one report in The Cancer Genome Atlas (TCGA) network showing one gastric cancer case with evidence of integration of the EBV genome into the human genome, in which multiple independent RNAseq reads revealed a fusion transcript predicted to join the first 20 amino acids of the human plasminogen receptor (PLGRKT, alias C9orf46) to almost the entire coding sequence of the early lytic EBV gene BHLF1 (alias EA-D) [<xref rid="R19" ref-type="bibr">19</xref>]. The expression patterns of some specific EBV genes define the type of latency into the cells (for review see [<xref rid="R20" ref-type="bibr">20</xref>]). In EBVaGC the virus shows a type I/II latency, where the most relevant genes associated with the pathogenesis are: EBV encoded RNAs (EBERs), the EBV Nuclear Antigens (EBNAs), the BamH1-A rightward transcripts (BARTs) and, apparently, some Latent Membrane proteins (LMP) genes are actively expressed [<xref rid="R17" ref-type="bibr">17</xref>]. The EBER-1 and -2 genes are the most abundant small non-coding RNAs that bind to host proteins and are generally used as a target for EBV detection by <italic>in situ</italic> hybridization (ISH) [<xref rid="R21" ref-type="bibr">21</xref>]. The EBNA-1 and -2 genes are exclusively nuclear proteins expressed in latent infected gastric carcinoma cells, and related with the disruption of promyelocytic leukemia nuclear bodies [<xref rid="R22" ref-type="bibr">22</xref>]. EBNA-1 is a DNA binding protein that lacks enzymatic activity, although is able to bind with some cellular proteins, such as CK2 and possibly P32/TAP [<xref rid="R23" ref-type="bibr">23</xref>]. In addition, an important partner of EBNA-1 is the ubiquitin-specific protease USP7, which is able to stabilize p53 and mdm2 [<xref rid="R24" ref-type="bibr">24</xref>]. Interestingly EBNA-1 is expressed in all of the EBV-associated tumors and is involved in viral DNA replication, mitotic segregation and transcriptional activation [<xref rid="R25" ref-type="bibr">25</xref>]. BART genes are highly expressed and multispliced RNAs whose protein-coding function is highly controversial [<xref rid="R26" ref-type="bibr">26</xref>]. Although some BARTs open reading frames (ORFs) have been predicted, it remains unclear whether any of them can be endogenously translated. In addition, BART small and long non-coding RNAs are highly expressed and associated with oncogenic transformation and immune evasion functions [<xref rid="R27" ref-type="bibr">27</xref>, <xref rid="R28" ref-type="bibr">28</xref>] (for review see [<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R20" ref-type="bibr">20</xref>]). The LMP-1 and -2 genes encode for transmembrane proteins, with a plethora of oncogenic functions with conflicting results in gastric carcinoma [<xref rid="R29" ref-type="bibr">29</xref>, <xref rid="R30" ref-type="bibr">30</xref>]. Interestingly, variations in its sequences might be associated with phylogeographic diversity of EBV strains in EBVaGC throughout the world [<xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R32" ref-type="bibr">32</xref>]. Taken together, EBV latent genes not only define the type of latency, but are associated with oncogenic transformation, immune evasion, and the genetic diversity of EBVaGC.</p></sec></sec><sec id="s1_3"><title>EBV strains and EBV-associated gastric carcinoma</title><p>Previous characterization of restriction fragment length polymorphisms (RFLP) and the recently completed genome sequencing of 31 viruses lead towards the first global assessment of the genetic diversity of EBV. Twenty-five of these sequences were obtained from viruses present in malignant tumors, including 9 EBVaGC [<xref rid="R33" ref-type="bibr">33</xref>] and 7 cases which were isolated from benign lesions or healthy individuals [<xref rid="R34" ref-type="bibr">34</xref>&#x02013;<xref rid="R37" ref-type="bibr">37</xref>]. Based on these data, five specific types (A, B, C, D and F) of EBV have been identified. Types A and B are defined by the substitution of 1.8 kb in the C-terminal domain of the EBNA-2 gene [<xref rid="R38" ref-type="bibr">38</xref>]. Subtype A is the predominant strain in Western and Asian countries, whereas subtype B is frequently found in Africa [<xref rid="R38" ref-type="bibr">38</xref>, <xref rid="R39" ref-type="bibr">39</xref>]. In addition, these two types of EBV differ in their capacity to transform B-lymphocytes to a proliferative state [<xref rid="R40" ref-type="bibr">40</xref>]. RFLPs at the BamHI W1/I1 boundary region identify subtypes C and D. Type C lacks the BamHI site and is more frequent in Asia among healthy individuals and EBV-associated diseases [<xref rid="R41" ref-type="bibr">41</xref>&#x02013;<xref rid="R44" ref-type="bibr">44</xref>]. Conversely, subtype D (which has retained the BamHI restriction site) prevails in Western countries [<xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R45" ref-type="bibr">45</xref>]. Another polymorphism at the BamHI site defines the F type, of which the prototype BamHI F virus is found worldwide, but the &#x02018;&#x02018;f&#x02019;&#x02019; variant, characterized by the presence of an extra BamHI site, is found only in cases of nasopharyngeal carcinomas (NPC) from Southern China [<xref rid="R46" ref-type="bibr">46</xref>]. Finally, two more variants of EBV have been described associated with the LMP-1 gene. A polymorphism of the Xho I restriction site at exon 1 of the LMP-1 gene (position 169425), defines western and Asian strains. The lack Xho I restriction site is common in healthy individuals and EBV-associated diseases in Asia [<xref rid="R41" ref-type="bibr">41</xref>], while the presence of the Xho I site is frequently observed in Western countries [<xref rid="R47" ref-type="bibr">47</xref>]. In addition, a C-terminal 30-base pair deletion (position 168287&#x02013;168256) of the LMP-1 gene has been described [<xref rid="R48" ref-type="bibr">48</xref>]. However, this variant has not been associated with any specific geographical areas.</p></sec><sec id="s1_4"><title>Relevance of EBV strain variations in EBV-associated gastric carcinoma in the Americas</title><p>Corvalan and coworkers [<xref rid="R31" ref-type="bibr">31</xref>] found that both polymorphisms at the BamHI W1/I1 boundary region (subtypes C and D) and Xho I RFLPs at exon 1 of the LMP-1 gene were present in healthy donors. These authors also identified 2 unique novel recombinant strains, the type C/kept Xho I site and type D/lack of Xho I site [<xref rid="R31" ref-type="bibr">31</xref>]. These findings reflect the admixture of different ethnic populations in the Americas [<xref rid="R49" ref-type="bibr">49</xref>, <xref rid="R50" ref-type="bibr">50</xref>]. Interestingly, in the case of EBVaGCs, tumors harbor only the western genotype (subtype D and kept Xho I site) (<italic>p &#x0003c;</italic> 0.001). Accordingly, cosegregation of these polymorphisms in EBVaGC was highly significant (OR 16.3 [95% CI 2.5&#x02013;685]). A consolidated overview of EBV strains in healthy donors and EBVaGC in the Americas is shown in Table <xref ref-type="table" rid="T2">2</xref>. Taken together, these findings suggest that EBVaGC in the Americas might be almost exclusively associated to strains from western countries, despite the presence of recombinant strains among healthy donors. Similar findings have been described for <italic>H.pylori</italic> and gastric carcinoma, human papillomavirus and cervical cancer and <italic>M. tuberculosis</italic> and tuberculosis (for a review see [<xref rid="R51" ref-type="bibr">51</xref>]. In the case of <italic>H.pylori</italic> and gastric carcinoma, de Sablet et al. [<xref rid="R52" ref-type="bibr">52</xref>] identified that strains from the high-risk region were all of European origin, whereas those from the low-risk region were of either European (34%) or African origin (66%). Similar findings have been described for <italic>M. tuberculosis</italic> and human papillomavirus [<xref rid="R51" ref-type="bibr">51</xref>] and the concept of &#x0201c;disrupted co-evolution&#x0201d; between the pathogen and its host has been proposed as a contributor for the phylogeographic origin of disease. Here, we propose that this might be the case for EBVaGC, where both Western and Asian wild-type strains and recombinant strains are present in healthy donors. However, only the western wild-type strain is present in gastric cancer. The natural variation of EBV should be further inquired by sequencing a large number of EBV-positive gastric cancer cases and healthy donors.</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>EBV strains in healthy donors (HD) and EBV-associated gastric carcinoma in the Americas</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1"/><th colspan="5" align="center" valign="middle" rowspan="1">EBNA</th><th colspan="5" align="center" valign="middle" rowspan="1">F/f variant</th><th colspan="5" align="center" valign="middle" rowspan="1">type C/D</th><th colspan="5" align="center" valign="middle" rowspan="1">XhoI kept/loss</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1"/><th align="left" valign="middle" rowspan="1" colspan="1"/><th colspan="2" align="center" valign="middle" rowspan="1">A</th><th colspan="3" align="center" valign="middle" rowspan="1">B</th><th colspan="2" align="center" valign="middle" rowspan="1">F</th><th colspan="3" align="center" valign="middle" rowspan="1">f</th><th colspan="2" align="center" valign="middle" rowspan="1">C</th><th colspan="3" align="center" valign="middle" rowspan="1">D</th><th colspan="2" align="center" valign="middle" rowspan="1">kept</th><th colspan="3" align="center" valign="middle" rowspan="1">loss</th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">References</th><th align="center" valign="middle" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" rowspan="1" colspan="1">EBVaGC</th><th align="center" valign="middle" rowspan="1" colspan="1">HD</th><th align="center" valign="middle" rowspan="1" colspan="1">EBVaGC</th><th align="center" valign="middle" rowspan="1" colspan="1">HD</th><th align="center" valign="middle" rowspan="1" colspan="1">p value</th><th align="center" valign="middle" rowspan="1" colspan="1">EBVaGC</th><th align="center" valign="middle" rowspan="1" colspan="1">HD</th><th align="center" valign="middle" rowspan="1" colspan="1">EBVaGC</th><th align="center" valign="middle" rowspan="1" colspan="1">HD</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic> value</th><th align="center" valign="middle" rowspan="1" colspan="1">EBVaGC</th><th align="center" valign="middle" rowspan="1" colspan="1">HD</th><th align="center" valign="middle" rowspan="1" colspan="1">EBVaGC</th><th align="center" valign="middle" rowspan="1" colspan="1">HD</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic> value</th><th align="center" valign="middle" rowspan="1" colspan="1">EBVaGC</th><th align="center" valign="middle" rowspan="1" colspan="1">HD</th><th align="center" valign="middle" rowspan="1" colspan="1">EBVaGC</th><th align="center" valign="middle" rowspan="1" colspan="1">HD</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Herrera-Goepfert et al. (2005)</td><td align="center" valign="middle" rowspan="1" colspan="1">Mexico</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Corval&#x000e1;n et al. (2006)</td><td align="center" valign="middle" rowspan="1" colspan="1">Colombia</td><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">159</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.048176</td><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.046186</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">116</td><td align="center" valign="middle" rowspan="1" colspan="1">0.026917</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">115</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">55</td><td align="center" valign="middle" rowspan="1" colspan="1">0.043103</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ordonez et al. (2011)</td><td align="center" valign="middle" rowspan="1" colspan="1">Peru</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">101</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.00088</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">105</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Corval&#x000e1;n et al. (2006)</td><td align="center" valign="middle" rowspan="1" colspan="1">Chile</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td><td align="center" valign="middle" rowspan="1" colspan="1">98</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27439</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">94</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.012438</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">45</td><td align="center" valign="middle" rowspan="1" colspan="1">35</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">35</td><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">45</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Consolidate</td><td align="center" valign="middle" rowspan="1" colspan="1">64</td><td align="center" valign="middle" rowspan="1" colspan="1">257</td><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">0.072</td><td align="center" valign="middle" rowspan="1" colspan="1">74</td><td align="center" valign="middle" rowspan="1" colspan="1">194</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">186</td><td align="center" valign="middle" rowspan="1" colspan="1">68</td><td align="center" valign="middle" rowspan="1" colspan="1">187</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">70</td><td align="center" valign="middle" rowspan="1" colspan="1">151</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">160</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr></tbody></table></table-wrap></sec><sec id="s1_5"><title>Role of host molecular signaling in the pathogenesis of EBV-associated gastric carcinoma</title><p>The TCGA network has proposed a novel molecular classification of gastric carcinoma that recognizes, for the first time, a subtype of tumors positive for Epstein-Barr virus: the EBVaGC. This subtype often displays frequent <italic>PIK3CA</italic> mutations, amplification of <italic>JAK2</italic>, CD274 (also known as PD-L1) and <italic>PDCD1LG2</italic> (also known as PD-L2), as well as unique CpG island methylator phenotype (CIMP) [<xref rid="R4" ref-type="bibr">4</xref>]. Although overexpression of PIK3CA has not been significantly associated with any clinicopathological features, loss of <italic>PTEN</italic>, a negative regulator of <italic>PIK3CA</italic>, was independently associated with poor prognosis (<italic>p =</italic> 0.011) [<xref rid="R53" ref-type="bibr">53</xref>]. It has been proposed that the PI3K/AKT signaling pathway might also contribute to the switch from latency to the lytic state of the virus, a process known as EBV reactivation [<xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R55" ref-type="bibr">55</xref>]. Iwakiri and Takada [<xref rid="R56" ref-type="bibr">56</xref>] have shown that PI3K/AKT signal transduction contributes to the transcription of the BZLF1 gene, the master regulator of the lytic cycle and one of the most important genes in the reactivation of the EBV [<xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R55" ref-type="bibr">55</xref>]. The main EBV oncoproteins LMP-1 and -2 can activate the PI3K/AKT pathway through the CTAR regions of their transmembrane domains, activating downstream signaling pathways [<xref rid="R57" ref-type="bibr">57</xref>]. Polymorphisms of Xho I site at exon 1 of the LMP-1 gene [<xref rid="R31" ref-type="bibr">31</xref>] might influence this activation favoring global differences of EBVaGC. Further experiments to confirm this issue are warranted. The JAK/STAT pathway is involved in a range of physiological and cellular processes. <italic>JAK2</italic> gene is amplified and overexpressed in EBVaGCs, but no significant association with survival was found [<xref rid="R58" ref-type="bibr">58</xref>]. Administration of JAK2 inhibitors, such as AZD1480, AG-490 and WP-1066, may represent potential therapeutic strategies for EBVaGC [<xref rid="R59" ref-type="bibr">59</xref>&#x02013;<xref rid="R61" ref-type="bibr">61</xref>]. Significant amplification of PD-L1 was found in EBVaGC [<xref rid="R62" ref-type="bibr">62</xref>]. However, this finding was not associated with any clinicopathological characteristics or survival rates [<xref rid="R58" ref-type="bibr">58</xref>]. Interestingly, LMP-1 cooperates with IFN-gamma to increase the expression of PD-L1 and this overexpression is suppressed by knocking down LMP-1 in EBV positive cell lines [<xref rid="R63" ref-type="bibr">63</xref>]. One final characteristic of the EBVaGC by the TCGA is the highest frequency of DNA hypermethylation [<xref rid="R19" ref-type="bibr">19</xref>]. Evaluation of promoter and non-promoter CpG islands of the human genome has found that EBV infection leads to an extensive methylation of both host and viral genomes, being more extensive than any tumor type from the TCGA network [<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R64" ref-type="bibr">64</xref>, <xref rid="R65" ref-type="bibr">65</xref>]. In particular, hypermethylation of the CDKN2A promoter region has been detected in all studies [<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R66" ref-type="bibr">66</xref>&#x02013;<xref rid="R71" ref-type="bibr">71</xref>]. Whether specific patterns of DNA hypermethylation may be associated to EBVaGC in the Americas is another question which remains to be answered.</p></sec><sec id="s1_6"><title>Role of environmental conditions in the pathogenesis of EBV-associated gastric carcinoma</title><sec id="s1_6_1"><title>Birth order and age</title><p>In America, Campos et al. [<xref rid="R72" ref-type="bibr">72</xref>] reported that patients born as the eldest child showed the lowest frequency of EBVaGCs (OR = 0.2, 95% CI = 0.1&#x02013;0.8, <italic>P =</italic> 0.007). These findings were contrary to what has been reported in Asia, where EBVaGC was more frequently observed among eldest child [<xref rid="R73" ref-type="bibr">73</xref>]. In America, children got the first EBV infection at a younger age than in eastern populations [<xref rid="R74" ref-type="bibr">74</xref>]. This can be an important issue which should be further investigated. A relationship between EBVaGC and onset age for EBV infection has been reported in Mexican-descendants in the U.S, as well as residents from Mexico and Brazil [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R14" ref-type="bibr">14</xref>]. A proportion of EBVaGC at younger age has also been reported in Colombia and Chile [<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. Further research is required to clarify the relevance of this issue.</p></sec></sec><sec id="s1_7"><title>Tobacco and alcohol consumption</title><p>In Colombia, Mexico and Honduras, smoking has been associated to the onset of EBVaGC (48%, 43% and 46%, respectively) [<xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R75" ref-type="bibr">75</xref>&#x02013;<xref rid="R77" ref-type="bibr">77</xref>]. The association between alcohol consumption and the risk of EBVaGC has been explored in Honduras [<xref rid="R76" ref-type="bibr">76</xref>, <xref rid="R77" ref-type="bibr">77</xref>], presenting 43% of association. The relationship between smoking, EBV infection and the risk of developing gastric cancer should be an interesting topic for future investigation. An international case-case comparison of smoking and alcohol consumption associated with EBVaGC risk, including the aforementioned studies [<xref rid="R77" ref-type="bibr">77</xref>], indicate that smoking association is stronger for EBV-positive tumors (OR = 1.5 [95% CI 1.01&#x02013;2.3]). In the case of alcohol consumption, a null association was found [<xref rid="R77" ref-type="bibr">77</xref>]. Further research in the Americas will be necessary to better determine these associations.</p></sec><sec id="s1_8"><title>Diet</title><p>A study conducted in Cali, Colombia reported no associations between EBVaGC and high salt intake or exposure to metallic dust [<xref rid="R75" ref-type="bibr">75</xref>]. In addition, no significant associations were found with other dietary habits including salt, fruit and vegetable intake; steamed, fried or smoked foods; or food preparations by baking (oven), barbequing (coal) or roasting [<xref rid="R75" ref-type="bibr">75</xref>]. These results are unique to the Americas and contrary to those reported in Asia, where EBVaGC has been associated to metallic dust exposure and salt intake [<xref rid="R73" ref-type="bibr">73</xref>]. On the other hand, a study in Korean population reported that daily intake of the mycotoxin aflatoxin B1 (AFB1) was significantly higher among gastric cancer patients when compared with control subjects (1.65 &#x000b1; 0.72 and 1.91 &#x000b1; 0.87 ng/Kg/day, respectively, <italic>p &#x0003c;</italic> 0.0001) [<xref rid="R78" ref-type="bibr">78</xref>]. In addition, Accardi et al. [<xref rid="R79" ref-type="bibr">79</xref>] demonstrated that AFB1 stimulates EBV-mediated B-cell transformation using some <italic>in vitro</italic> and <italic>in vivo</italic> approaches, suggesting that this mycotoxin is a co-factor in EBV-mediated carcinogenesis [<xref rid="R79" ref-type="bibr">79</xref>]. Thus, the possibility that AFB1 works as a cofactor in EBVaGC in the Americas warrants additional epidemiological and laboratory research.</p></sec><sec id="s1_9"><title><italic>H.pylori</italic> infection</title><p>Infection with <italic>H.pylori</italic> is strongly associated with the progression of the gastric precancerous cascade and the development of intestinal type gastric cancer [<xref rid="R80" ref-type="bibr">80</xref>, <xref rid="R81" ref-type="bibr">81</xref>]. Camargo and coworkers [<xref rid="R82" ref-type="bibr">82</xref>] have recently compared <italic>H.pylori</italic> serologic profiles of EBV-positive and EBV-negative gastric cancer patients from five countries, including 2 from the Americas (Mexico and Honduras). These authors found a marginal statistical significance of catalase antibodies in the EBVaGC group (OR = 3.15 [95% CI =1.50&#x02013;6.61]) with no regional differences.</p></sec><sec id="s1_10"><title>EBVaGC and lymphoepithelioma-like carcinoma of the stomach</title><p>Watanabe and coworkers [<xref rid="R83" ref-type="bibr">83</xref>] described &#x0201c;gastric carcinoma with lymphoid stroma&#x0201d; as a group of tumors showing microalveolar, trabecular, or primitive-tubular patterns with uniformly dense and diffuse lymphoid cell infiltration (Figure <xref ref-type="fig" rid="F3">3</xref>). This unique phenotype was later defined as lymphoepithelioma-like (LEL) carcinoma and associated with EBV by 3 independent groups [<xref rid="R84" ref-type="bibr">84</xref>&#x02013;<xref rid="R86" ref-type="bibr">86</xref>], although it was also recently described as a feature of the MSI subtype of GC [<xref rid="R87" ref-type="bibr">87</xref>]. Tumor cells of LEL are immunohistochemically positive for AE3-defined keratin, confirming their epithelial nature. Therefore, the diffuse lymphoid infiltration is a mixture of CD3-positive T cells and CD20-positive B cells (Figure <xref ref-type="fig" rid="F3">3</xref>). The presence of EBV has been demonstrated in 80%&#x02013;86% of cases [<xref rid="R88" ref-type="bibr">88</xref>, <xref rid="R89" ref-type="bibr">89</xref>]. Retrospective evaluation of a 274-case series from a 14-year period (ordinary gastric carcinoma cases matched by age and sex) showed that LEL tumors had distinct clinicopathologic features and more favorable prognosis [<xref rid="R88" ref-type="bibr">88</xref>]. Interestingly, almost half of LEL EBV-positive cases with differentiated components showed the presence of EBV in the non-LEL component as well [<xref rid="R88" ref-type="bibr">88</xref>]. Gutierrez and colleagues [<xref rid="R90" ref-type="bibr">90</xref>] classified EBV into five subtypes, based on the EBNA-1 sequence in the carboxy-terminal region, which we have named according to the amino acid at position 487 in EBNA-1. Since this amino acid residue was highly predictive of the observed mutation patterns, they termed two of these subtypes as &#x02018;prototypes&#x02019; (P-ala and P-thr). On the other hand, they identified 3 other subtypes as &#x0201c;variants&#x0201d; (V-pro, V-leu and V-val), because they differed more markedly from P-ala than does P-thr. According to this EBV classification, Cheng and coworkers [<xref rid="R89" ref-type="bibr">89</xref>] compared clinical and molecular features of LEL EBV-positive with EBVaGC and demonstrated that the V-leu and P-ala subtypes were predominant in EBV-positive gastric LEL, which is different from the predominant V-val subtype in ordinary EBVaGC. In addition, EBV-positive gastric LELC has a favorable prognosis when compared to ordinary EBVaGC (median survival time 43.0 vs. 18.0 months, <italic>p</italic> = 0.035). In the Americas, LEL carcinomas have been included as part of an EBVaGC series with prevalences ranging from 1.1% in Chile to 7.6% in Brazil [<xref rid="R13" ref-type="bibr">13</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. Whether LEL is a variant of EBVaGC needs to be addressed in future investigations.</p><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Lymphoepithelioma-like (LEL) carcinoma</title><p>(<bold>A</bold>) (HE, 400&#x000d7;) shows a poorly differentiated carcinoma formed by medium to large size tumor cells with vesicular nuclei, prominent nucleoli and small amount of eosinophilic cytoplasm (inset) arranged in small clusters and poorly formed cords, intermingled with numerous lymphocytes. (<bold>B</bold>) (Pan-Cytokeratin AE1/AE3, 400&#x000d7;) shows that the tumor cells are positive for cytokeratins demonstrating their epithelial nature and highlighting the poorly formed clusters and cords arrangement. (<bold>C</bold>) (CD3, 400&#x000d7;) highlights the diffuse lymphocytic infiltrate composed mainly by mature T lymphocytes; tumor cells are negative for CD3 (inset). (<bold>D</bold>) (CD20, 400&#x000d7;) highlights scattered B-lymphocytes within the infiltrate.</p></caption><graphic xlink:href="oncotarget-08-75687-g003"/></fig></sec></sec><sec id="s2"><title>CONCLUSIONS</title><p>Novel molecular classifications and meta-analysis have identified EBV as a distinct etiological agent for gastric cancer. An important characteristic of EBVaGC is its higher prevalence in the Americas as compared to Asia. Our meta-analysis estimate a prevalence of 11.4% of EBV infection, more frequently observed in males with predominantly diffuse-type histology. Specific EBV genes such as EBERs, EBNAs, BARTs and LMP are the most actively expressed transcripts. Variations in the sequences of these genes might be associated with the observed phylogeographic diversity of EBV strains across the region. Polymorphisms at the BamHI W1/I1 boundary region and Xho I RFLPs at exon 1 of the LMP-1 gene have been found in healthy donors, reflecting the admixture of different ethnic populations in the Americas. However, this is not the case for gastric cancer, since almost all EBVaGCs harbor exclusively the western genotype (subtype D and kept Xho I site). We propose that &#x0201c;disrupted co-evolution&#x0201d; between EBV and healthy population might contribute to the origin of the disease. Patients born as the eldest child and age of onset of EBV infection are important issues that should be further investigated. Smoking is strong risk factor for EBV-positive tumors, but no associations have been found with dietary habits in the Americas. <italic>H.pylori</italic> infection identified a marginal statistical significance of catalase antibodies in the EBVaGC group. Finally, &#x0201c;gastric carcinomas with lymphoid stroma&#x0201d; described by Watanabe [<xref rid="R83" ref-type="bibr">83</xref>] is a common phenotype of MSI and EBV subtypes of GC [<xref rid="R87" ref-type="bibr">87</xref>]. LEL has been associated with EBV infection in more than 80% of cases, where most of LEL carcinomas have been included as part of EBVaGC series. Whether LEL is a variant of EBVaGC needs to be addressed in future investigations.</p><sec id="s2_1"><title>Search strategy and selection criteria</title><p>Data for this Review were identified by searches of PubMed/Scopus/Scielo from relevant articles published between 1959 and September 2016 in English, using the search terms &#x0201c;gastric cancer&#x0201d; and &#x0201c;Epstein-Barr virus&#x0201d; with special emphasis on articles published from the Americas (North, Central and South American countries). Epidemiological data were further searched by GLOBOCAN 2012 [<xref rid="R91" ref-type="bibr">91</xref>]. Only studies in which EBV was detected in primary tumors by <italic>in situ</italic> hybridization of EBER were considered. The resulting studies were manually curated according to their relevance to EBVaGC in the Americas and potentially relevant articles were then evaluated in detail. Meta-analyses summarizing frequencies of EBV by EBER in tumor gastric tissues from the Americas including information on the first author, year of publication, tumor location, size of study population and age and sex of the patients (Table <xref ref-type="table" rid="T1">1</xref>). Due to the small number of studies available, clinical data were restricted to the variables mentioned above. Meta-analyses were performed by a random-effects model with the Inverse variance method, using the DerSimonian-Laird estimator, a logit transformation, and the Clopper-Pearson confidence interval for individual studies. The results are shown in a log-scale. The I2 statistic, which measures the extent of inconsistency between studies, was assessed. The 95% confidence interval of the odds ratio was used to evaluate differences between groups. Meta-analyses methods are presented in the footnotes of figures and tables.</p></sec></sec><sec id="s3"><title>DISCLAIMER</title><p>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.</p></sec></body><back><fn-group><fn fn-type="con"><p><bold>Authors&#x02019; contributions</bold></p><p>Gonzalo Carrasco: Conception or design of the work, Data collection, Data analysis and interpretation, Drafting the article, Critical revision of the article, Final approval of the version to be published.</p><p>Ismael Riquelme: Data collection, Drafting the article, Critical revision of the article, Final approval of the version to be published.</p><p>Oslando Padilla: Data analysis and interpretation, Critical revision of the article, Final approval of the version to be published.</p><p>Miguel Villaseca: Data collection, Drafting the article, Critical revision of the article, Final approval of the version to be published.</p><p>Francisco R. Aguayo: Drafting the article, Critical revision of the article, Final approval of the version to be published.</p><p>Alejandro H. Corvalan: Conception or design of the work, Data collection, Data analysis and interpretation, Drafting the article, Critical revision of the article, Final approval of the version to be published.</p></fn></fn-group><ack><p>CONICYT-FONDAP 15130011, Fondecyt 1151411 and Fondecyt 1161219 from the Government of Chile.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>CONFLICTS OF INTEREST</bold></p><p>The authors declare that there is no conflicts of interests regarding the publication of this paper.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name><name name-style="western"><surname>Soerjomataram</surname><given-names>I</given-names></name><name name-style="western"><surname>Dikshit</surname><given-names>R</given-names></name><name name-style="western"><surname>Eser</surname><given-names>S</given-names></name><name name-style="western"><surname>Mathers</surname><given-names>C</given-names></name><name name-style="western"><surname>Rebelo</surname><given-names>M</given-names></name><name name-style="western"><surname>Parkin</surname><given-names>DM</given-names></name><name name-style="western"><surname>Forman</surname><given-names>D</given-names></name><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name></person-group><article-title>Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012</article-title><source>Int J Cancer</source><year>2015</year><volume>136</volume><fpage>E359</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1002/ijc.29210</pub-id><pub-id pub-id-type="pmid">25220842</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chatenoud</surname><given-names>L</given-names></name><name name-style="western"><surname>Bertuccio</surname><given-names>P</given-names></name><name name-style="western"><surname>Bosetti</surname><given-names>C</given-names></name><name name-style="western"><surname>Malvezzi</surname><given-names>M</given-names></name><name name-style="western"><surname>Levi</surname><given-names>F</given-names></name><name name-style="western"><surname>Negri</surname><given-names>E</given-names></name><name name-style="western"><surname>La Vecchia</surname><given-names>C</given-names></name></person-group><article-title>Trends in mortality from major cancers in the Americas: 1980&#x02013;2010</article-title><source>Ann Oncol</source><year>2014</year><volume>25</volume><fpage>1843</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdu206</pub-id><pub-id pub-id-type="pmid">24907637</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathers</surname><given-names>CD</given-names></name><name name-style="western"><surname>Loncar</surname><given-names>D</given-names></name></person-group><article-title>Projections of global mortality and burden of disease from 2002 to 2030</article-title><source>PLoS Med</source><year>2006</year><volume>3</volume><fpage>e442</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0030442</pub-id><pub-id pub-id-type="pmid">17132052</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bass</surname><given-names>AJ</given-names></name></person-group><article-title>Comprehensive molecular characterization of gastric adenocarcinoma</article-title><source>Nature</source><year>2014</year><volume>513</volume><fpage>202</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/nature13480</pub-id><pub-id pub-id-type="pmid">25079317</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><name name-style="western"><surname>Han</surname><given-names>SH</given-names></name><name name-style="western"><surname>An</surname><given-names>JS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>ES</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YS</given-names></name></person-group><article-title>Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis</article-title><source>J Gastroenterol Hepatol</source><year>2009</year><volume>24</volume><fpage>354</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2009.05775.x</pub-id><pub-id pub-id-type="pmid">19335785</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>G</given-names></name><name name-style="western"><surname>Pfeiffer</surname><given-names>R</given-names></name><name name-style="western"><surname>Camargo</surname><given-names>MC</given-names></name><name name-style="western"><surname>Rabkin</surname><given-names>CS</given-names></name></person-group><article-title>Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location</article-title><source>Gastroenterology</source><year>2009</year><volume>137</volume><fpage>824</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2009.05.001</pub-id><pub-id pub-id-type="pmid">19445939</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camargo</surname><given-names>MC</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>G</given-names></name><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Pfeiffer</surname><given-names>RM</given-names></name><name name-style="western"><surname>Kim</surname><given-names>WH</given-names></name><name name-style="western"><surname>Herrera-Goepfert</surname><given-names>R</given-names></name><name name-style="western"><surname>Corval&#x000e1;n</surname><given-names>AH</given-names></name><name name-style="western"><surname>Carrascal</surname><given-names>E</given-names></name><name name-style="western"><surname>Abdirad</surname><given-names>A</given-names></name><name name-style="western"><surname>Anwar</surname><given-names>M</given-names></name><name name-style="western"><surname>Hao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kattoor</surname><given-names>J</given-names></name><name name-style="western"><surname>Yoshiwara-Wakabayashi</surname><given-names>E</given-names></name><etal/></person-group><article-title>Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis</article-title><source>Br J Cancer</source><year>2011</year><volume>105</volume><fpage>38</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1038/bjc.2011.215</pub-id><pub-id pub-id-type="pmid">21654677</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shibata</surname><given-names>D</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>LM</given-names></name></person-group><article-title>Epstein-Barr virus-associated gastric adenocarcinoma</article-title><source>Am J Pathol</source><year>1992</year><volume>140</volume><fpage>769</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">1314023</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulley</surname><given-names>ML</given-names></name><name name-style="western"><surname>Pulitzer</surname><given-names>DR</given-names></name><name name-style="western"><surname>Eagan</surname><given-names>PA</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>BG</given-names></name></person-group><article-title>Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation</article-title><source>Hum Pathol</source><year>1996</year><volume>27</volume><fpage>20</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8543306</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vo</surname><given-names>QN</given-names></name><name name-style="western"><surname>Geradts</surname><given-names>J</given-names></name><name name-style="western"><surname>Gulley</surname><given-names>ML</given-names></name><name name-style="western"><surname>Boudreau</surname><given-names>DA</given-names></name><name name-style="western"><surname>Bravo</surname><given-names>JC</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>BG</given-names></name></person-group><article-title>Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation</article-title><source>J Clin Pathol</source><year>2002</year><volume>55</volume><fpage>669</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">12194996</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herrera-Goepfert</surname><given-names>R</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>S</given-names></name><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Ding</surname><given-names>S</given-names></name><name name-style="western"><surname>Reyes</surname><given-names>E</given-names></name><name name-style="western"><surname>Itoh</surname><given-names>T</given-names></name><name name-style="western"><surname>Minakami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Eizuru</surname><given-names>Y</given-names></name></person-group><article-title>Epstein-Barr virus-associated gastric carcinoma: Evidence of age-dependence among a Mexican population</article-title><source>World J Gastroenterol</source><year>2005</year><volume>11</volume><fpage>6096</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">16273633</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrascal</surname><given-names>E</given-names></name><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>S</given-names></name><name name-style="western"><surname>Tamayo</surname><given-names>O</given-names></name><name name-style="western"><surname>Itoh</surname><given-names>T</given-names></name><name name-style="western"><surname>Eizuru</surname><given-names>Y</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>F</given-names></name><name name-style="western"><surname>Sera</surname><given-names>M</given-names></name><name name-style="western"><surname>Carrasquilla</surname><given-names>G</given-names></name><name name-style="western"><surname>Piazuelo</surname><given-names>MB</given-names></name><name name-style="western"><surname>Florez</surname><given-names>L</given-names></name><name name-style="western"><surname>Bravo</surname><given-names>JC</given-names></name></person-group><article-title>Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia</article-title><source>Oncol Rep</source><year>2003</year><volume>10</volume><fpage>1059</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">12792770</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>S</given-names></name><name name-style="western"><surname>Iriya</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamaguti</surname><given-names>T</given-names></name><name name-style="western"><surname>Hamada</surname><given-names>GS</given-names></name><name name-style="western"><surname>Itoh</surname><given-names>T</given-names></name><name name-style="western"><surname>Eizuru</surname><given-names>Y</given-names></name><name name-style="western"><surname>Aikou</surname><given-names>T</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Tsugane</surname><given-names>S</given-names></name><name name-style="western"><surname>Tokunaga</surname><given-names>M</given-names></name></person-group><article-title>Epstein-Barr virus-associated gastric carcinoma in Japanese Brazilians and non-Japanese Brazilians in Sao Paulo</article-title><source>Jpn J Cancer Res</source><year>2001</year><volume>92</volume><fpage>911</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11572757</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopes</surname><given-names>LF</given-names></name><name name-style="western"><surname>Bacchi</surname><given-names>MM</given-names></name><name name-style="western"><surname>Elgui-de-Oliveira</surname><given-names>D</given-names></name><name name-style="western"><surname>Zanati</surname><given-names>SG</given-names></name><name name-style="western"><surname>Alvarenga</surname><given-names>M</given-names></name><name name-style="western"><surname>Bacchi</surname><given-names>CE</given-names></name></person-group><article-title>Epstein-Barr virus infection and gastric carcinoma in Sao Paulo State, Brazil</article-title><source>Braz J Med Biol Res</source><year>2004</year><volume>37</volume><fpage>1707</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15517087</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshiwara</surname><given-names>E</given-names></name><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>S</given-names></name><name name-style="western"><surname>Itoh</surname><given-names>T</given-names></name><name name-style="western"><surname>Minakami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chirinos</surname><given-names>JL</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>J</given-names></name><name name-style="western"><surname>Takano</surname><given-names>J</given-names></name><name name-style="western"><surname>Miyagui</surname><given-names>J</given-names></name><name name-style="western"><surname>Hidalgo</surname><given-names>H</given-names></name><name name-style="western"><surname>Chacon</surname><given-names>P</given-names></name><name name-style="western"><surname>Linares</surname><given-names>V</given-names></name><name name-style="western"><surname>Eizuru</surname><given-names>Y</given-names></name></person-group><article-title>Epstein-Barr virus-associated gastric carcinoma in Lima, Peru</article-title><source>J Exp Clin Cancer Res</source><year>2005</year><volume>24</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15943031</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corval&#x000e1;n</surname><given-names>AH</given-names></name><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>S</given-names></name><name name-style="western"><surname>Eizuru</surname><given-names>Y</given-names></name><name name-style="western"><surname>Backhouse</surname><given-names>C</given-names></name><name name-style="western"><surname>Palma</surname><given-names>M</given-names></name><name name-style="western"><surname>Argandona</surname><given-names>J</given-names></name><name name-style="western"><surname>Tokunaga</surname><given-names>M</given-names></name></person-group><article-title>Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile</article-title><source>Int J Cancer</source><year>2001</year><volume>94</volume><fpage>527</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1002/ijc.1510</pub-id><pub-id pub-id-type="pmid">11745439</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsao</surname><given-names>SW</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>CM</given-names></name><name name-style="western"><surname>To</surname><given-names>KF</given-names></name><name name-style="western"><surname>Lo</surname><given-names>KW</given-names></name></person-group><article-title>The role of Epstein-Barr virus in epithelial malignancies</article-title><source>J Pathol</source><year>2015</year><volume>235</volume><fpage>323</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1002/path.4448</pub-id><pub-id pub-id-type="pmid">25251730</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lieberman</surname><given-names>PM</given-names></name></person-group><article-title>Chromatin Structure of Epstein-Barr Virus Latent Episomes</article-title><source>Curr Top Microbiol Immunol</source><year>2015</year><volume>390</volume><fpage>71</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-22822-8_5</pub-id><pub-id pub-id-type="pmid">26424644</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulley</surname><given-names>ML</given-names></name></person-group><article-title>Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma</article-title><source>Exp Mol Med</source><year>2015</year><volume>47</volume><fpage>e134</fpage><pub-id pub-id-type="doi">10.1038/emm.2014.93</pub-id><pub-id pub-id-type="pmid">25613731</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shinozaki-Ushiku</surname><given-names>A</given-names></name><name name-style="western"><surname>Kunita</surname><given-names>A</given-names></name><name name-style="western"><surname>Fukayama</surname><given-names>M</given-names></name></person-group><article-title>Update on Epstein-Barr virus and gastric cancer (review)</article-title><source>Int J Oncol</source><year>2015</year><volume>46</volume><fpage>1421</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.3892/ijo.2015.2856</pub-id><pub-id pub-id-type="pmid">25633561</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>LM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YY</given-names></name></person-group><article-title>EBER <italic>in situ</italic> hybridization for Epstein-Barr virus</article-title><source>Methods Mol Biol</source><year>2013</year><volume>999</volume><fpage>223</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1007/978-1-62703-357-2_16</pub-id><pub-id pub-id-type="pmid">23666702</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sivachandran</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Frappier</surname><given-names>L</given-names></name></person-group><article-title>Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection</article-title><source>J Virol</source><year>2012</year><volume>86</volume><fpage>6146</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1128/JVI.00013-12</pub-id><pub-id pub-id-type="pmid">22491455</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malik-Soni</surname><given-names>N</given-names></name><name name-style="western"><surname>Frappier</surname><given-names>L</given-names></name></person-group><article-title>Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections</article-title><source>J Virol</source><year>2012</year><volume>86</volume><fpage>6999</fpage><lpage>7002</lpage><pub-id pub-id-type="doi">10.1128/jvi.00194-12</pub-id><pub-id pub-id-type="pmid">22496234</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frappier</surname><given-names>L</given-names></name><name name-style="western"><surname>Verrijzer</surname><given-names>CP</given-names></name></person-group><article-title>Gene expression control by protein deubiquitinases</article-title><source>Curr Opin Genet Dev</source><year>2011</year><volume>21</volume><fpage>207</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2011.02.005</pub-id><pub-id pub-id-type="pmid">21411309</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frappier</surname><given-names>L</given-names></name></person-group><article-title>EBNA1</article-title><source>Curr Top Microbiol Immunol</source><year>2015</year><volume>391</volume><fpage>3</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-22834-1_1</pub-id><pub-id pub-id-type="pmid">26428370</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skalsky</surname><given-names>RL</given-names></name><name name-style="western"><surname>Cullen</surname><given-names>BR</given-names></name></person-group><article-title>EBV Noncoding RNAs</article-title><source>Curr Top Microbiol Immunol</source><year>2015</year><volume>391</volume><fpage>181</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-22834-1_6</pub-id><pub-id pub-id-type="pmid">26428375</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marquitz</surname><given-names>AR</given-names></name><name name-style="western"><surname>Mathur</surname><given-names>A</given-names></name><name name-style="western"><surname>Nam</surname><given-names>CS</given-names></name><name name-style="western"><surname>Raab-Traub</surname><given-names>N</given-names></name></person-group><article-title>The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim</article-title><source>Virology</source><year>2011</year><volume>412</volume><fpage>392</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2011.01.028</pub-id><pub-id pub-id-type="pmid">21333317</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marquitz</surname><given-names>AR</given-names></name><name name-style="western"><surname>Mathur</surname><given-names>A</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>RH</given-names></name><name name-style="western"><surname>Raab-Traub</surname><given-names>N</given-names></name></person-group><article-title>Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region</article-title><source>J Virol</source><year>2015</year><volume>89</volume><fpage>11256</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1128/JVI.01492-15</pub-id><pub-id pub-id-type="pmid">26311882</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XF</given-names></name><name name-style="western"><surname>Liang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yan</surname><given-names>LP</given-names></name><name name-style="western"><surname>Huang</surname><given-names>BH</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>P</given-names></name></person-group><article-title>Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas</article-title><source>World J Gastroenterol</source><year>2005</year><volume>11</volume><fpage>629</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">15655811</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Accardi</surname><given-names>R</given-names></name><name name-style="western"><surname>Fathallah</surname><given-names>I</given-names></name><name name-style="western"><surname>Gruffat</surname><given-names>H</given-names></name><name name-style="western"><surname>Mariggio</surname><given-names>G</given-names></name><name name-style="western"><surname>Le Calvez-Kelm</surname><given-names>F</given-names></name><name name-style="western"><surname>Voegele</surname><given-names>C</given-names></name><name name-style="western"><surname>Bartosch</surname><given-names>B</given-names></name><name name-style="western"><surname>Hernandez-Vargas</surname><given-names>H</given-names></name><name name-style="western"><surname>McKay</surname><given-names>J</given-names></name><name name-style="western"><surname>Sylla</surname><given-names>BS</given-names></name><name name-style="western"><surname>Manet</surname><given-names>E</given-names></name><name name-style="western"><surname>Tommasino</surname><given-names>M</given-names></name></person-group><article-title>Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein DeltaNp73alpha</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><fpage>e1003186</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1003186</pub-id><pub-id pub-id-type="pmid">23516355</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corval&#x000e1;n</surname><given-names>AH</given-names></name><name name-style="western"><surname>Ding</surname><given-names>S</given-names></name><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Carrascal</surname><given-names>E</given-names></name><name name-style="western"><surname>Carrasquilla</surname><given-names>G</given-names></name><name name-style="western"><surname>Backhouse</surname><given-names>C</given-names></name><name name-style="western"><surname>Urzua</surname><given-names>L</given-names></name><name name-style="western"><surname>Argandona</surname><given-names>J</given-names></name><name name-style="western"><surname>Palma</surname><given-names>M</given-names></name><name name-style="western"><surname>Eizuru</surname><given-names>Y</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>S</given-names></name></person-group><article-title>Association of a distinctive strain of Epstein-Barr virus with gastric cancer</article-title><source>Int J Cancer</source><year>2006</year><volume>118</volume><fpage>1736</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1002/ijc.21530</pub-id><pub-id pub-id-type="pmid">16217758</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>JN</given-names></name><name name-style="western"><surname>Ding</surname><given-names>YG</given-names></name><name name-style="western"><surname>Feng</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Li</surname><given-names>HG</given-names></name><name name-style="western"><surname>He</surname><given-names>D</given-names></name><name name-style="western"><surname>Du</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>B</given-names></name><name name-style="western"><surname>Shao</surname><given-names>CK</given-names></name></person-group><article-title>Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China</article-title><source>J Med Virol</source><year>2010</year><volume>82</volume><fpage>658</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1002/jmv.21731</pub-id><pub-id pub-id-type="pmid">20166192</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ji</surname><given-names>J</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ke</surname><given-names>Y</given-names></name></person-group><article-title>Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC)</article-title><source>Oncotarget</source><year>2015</year><volume>7</volume><fpage>4903</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.6751</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baer</surname><given-names>R</given-names></name><name name-style="western"><surname>Bankier</surname><given-names>AT</given-names></name><name name-style="western"><surname>Biggin</surname><given-names>MD</given-names></name><name name-style="western"><surname>Deininger</surname><given-names>PL</given-names></name><name name-style="western"><surname>Farrell</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Hatfull</surname><given-names>G</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>GS</given-names></name><name name-style="western"><surname>Satchwell</surname><given-names>SC</given-names></name><name name-style="western"><surname>Seguin</surname><given-names>C</given-names></name><name name-style="western"><surname>Tuffnell</surname><given-names>PS</given-names></name><name name-style="western"><surname>Barrell</surname><given-names>BG</given-names></name></person-group><article-title>DNA sequence and expression of the B95-8 Epstein-Barr virus genome</article-title><source>Nature</source><year>1984</year><volume>310</volume><fpage>207</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">6087149</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Jesus</surname><given-names>O</given-names></name><name name-style="western"><surname>Smith</surname><given-names>PR</given-names></name><name name-style="western"><surname>Spender</surname><given-names>LC</given-names></name><name name-style="western"><surname>Elgueta Karstegl</surname><given-names>C</given-names></name><name name-style="western"><surname>Niller</surname><given-names>HH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D</given-names></name><name name-style="western"><surname>Farrell</surname><given-names>PJ</given-names></name></person-group><article-title>Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV</article-title><source>J Gen Virol</source><year>2003</year><volume>84</volume><fpage>1443</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1099/vir.0.19054-0</pub-id><pub-id pub-id-type="pmid">12771413</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tan</surname><given-names>IB</given-names></name><name name-style="western"><surname>Das</surname><given-names>K</given-names></name><name name-style="western"><surname>Deng</surname><given-names>N</given-names></name><name name-style="western"><surname>Zouridis</surname><given-names>H</given-names></name><name name-style="western"><surname>Pattison</surname><given-names>S</given-names></name><name name-style="western"><surname>Chua</surname><given-names>C</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Guan</surname><given-names>YK</given-names></name><name name-style="western"><surname>Ooi</surname><given-names>CH</given-names></name><name name-style="western"><surname>Ivanova</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M</given-names></name><etal/></person-group><article-title>Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil</article-title><source>Gastroenterology</source><year>2013</year><volume>145</volume><fpage>554</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.05.010</pub-id><pub-id pub-id-type="pmid">23684942</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santpere</surname><given-names>G</given-names></name><name name-style="western"><surname>Darre</surname><given-names>F</given-names></name><name name-style="western"><surname>Blanco</surname><given-names>S</given-names></name><name name-style="western"><surname>Alcami</surname><given-names>A</given-names></name><name name-style="western"><surname>Villoslada</surname><given-names>P</given-names></name><name name-style="western"><surname>Mar Alba</surname><given-names>M</given-names></name><name name-style="western"><surname>Navarro</surname><given-names>A</given-names></name></person-group><article-title>Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project</article-title><source>Genome Biol Evol</source><year>2014</year><volume>6</volume><fpage>846</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1093/gbe/evu054</pub-id><pub-id pub-id-type="pmid">24682154</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zimber</surname><given-names>U</given-names></name><name name-style="western"><surname>Adldinger</surname><given-names>HK</given-names></name><name name-style="western"><surname>Lenoir</surname><given-names>GM</given-names></name><name name-style="western"><surname>Vuillaume</surname><given-names>M</given-names></name><name name-style="western"><surname>Knebel-Doeberitz</surname><given-names>MV</given-names></name><name name-style="western"><surname>Laux</surname><given-names>G</given-names></name><name name-style="western"><surname>Desgranges</surname><given-names>C</given-names></name><name name-style="western"><surname>Wittmann</surname><given-names>P</given-names></name><name name-style="western"><surname>Freese</surname><given-names>UK</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>U</given-names></name></person-group><article-title>Geographical prevalence of two types of Epstein-Barr virus</article-title><source>Virology</source><year>1986</year><volume>154</volume><fpage>56</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">3019008</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>LS</given-names></name><name name-style="western"><surname>Yao</surname><given-names>QY</given-names></name><name name-style="western"><surname>Rooney</surname><given-names>CM</given-names></name><name name-style="western"><surname>Sculley</surname><given-names>TB</given-names></name><name name-style="western"><surname>Moss</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Rupani</surname><given-names>H</given-names></name><name name-style="western"><surname>Laux</surname><given-names>G</given-names></name><name name-style="western"><surname>Bornkamm</surname><given-names>GW</given-names></name><name name-style="western"><surname>Rickinson</surname><given-names>AB</given-names></name></person-group><article-title>New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas</article-title><source>J Gen Virol</source><year>1987</year><volume>68</volume><fpage>2853</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-68-11-2853</pub-id><pub-id pub-id-type="pmid">2824665</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>LS</given-names></name><name name-style="western"><surname>Murray</surname><given-names>PG</given-names></name></person-group><article-title>Epstein-Barr virus and oncogenesis: from latent genes to tumours</article-title><source>Oncogene</source><year>2003</year><volume>22</volume><fpage>5108</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1206556</pub-id><pub-id pub-id-type="pmid">12910248</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lung</surname><given-names>ML</given-names></name><name name-style="western"><surname>Chang</surname><given-names>RS</given-names></name><name name-style="western"><surname>Jones</surname><given-names>JH</given-names></name></person-group><article-title>Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers</article-title><source>J Virol</source><year>1988</year><volume>62</volume><fpage>3862</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2901499</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lung</surname><given-names>ML</given-names></name><name name-style="western"><surname>Chang</surname><given-names>GC</given-names></name></person-group><article-title>Detection of distinct Epstein-Barr virus genotypes in NPC biopsies from southern Chinese and Caucasians</article-title><source>Int J Cancer</source><year>1992</year><volume>52</volume><fpage>34</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1323539</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sidagis</surname><given-names>J</given-names></name><name name-style="western"><surname>Ueno</surname><given-names>K</given-names></name><name name-style="western"><surname>Tokunaga</surname><given-names>M</given-names></name><name name-style="western"><surname>Ohyama</surname><given-names>M</given-names></name><name name-style="western"><surname>Eizuru</surname><given-names>Y</given-names></name></person-group><article-title>Molecular epidemiology of Epstein-Barr virus (EBV) in EBV-related malignancies</article-title><source>Int J Cancer</source><year>1997</year><volume>72</volume><fpage>72</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9212226</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lung</surname><given-names>ML</given-names></name><name name-style="western"><surname>Chang</surname><given-names>RS</given-names></name><name name-style="western"><surname>Huang</surname><given-names>ML</given-names></name><name name-style="western"><surname>Guo</surname><given-names>HY</given-names></name><name name-style="western"><surname>Choy</surname><given-names>D</given-names></name><name name-style="western"><surname>Sham</surname><given-names>J</given-names></name><name name-style="western"><surname>Tsao</surname><given-names>SY</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>P</given-names></name><name name-style="western"><surname>Ng</surname><given-names>MH</given-names></name></person-group><article-title>Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China</article-title><source>Virology</source><year>1990</year><volume>177</volume><fpage>44</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">2162115</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdel-Hamid</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Constantine</surname><given-names>N</given-names></name><name name-style="western"><surname>Massoud</surname><given-names>M</given-names></name><name name-style="western"><surname>Raab-Traub</surname><given-names>N</given-names></name></person-group><article-title>EBV strain variation: geographical distribution and relation to disease state</article-title><source>Virology</source><year>1992</year><volume>190</volume><fpage>168</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">1356286</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lung</surname><given-names>ML</given-names></name><name name-style="western"><surname>Lam</surname><given-names>WP</given-names></name><name name-style="western"><surname>Sham</surname><given-names>J</given-names></name><name name-style="western"><surname>Choy</surname><given-names>D</given-names></name><name name-style="western"><surname>Yong-Sheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Guo</surname><given-names>HY</given-names></name><name name-style="western"><surname>Ng</surname><given-names>MH</given-names></name></person-group><article-title>Detection and prevalence of the "f" variant of Epstein-Barr virus in southern China</article-title><source>Virology</source><year>1991</year><volume>185</volume><fpage>67</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">1656606</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khanim</surname><given-names>F</given-names></name><name name-style="western"><surname>Yao</surname><given-names>QY</given-names></name><name name-style="western"><surname>Niedobitek</surname><given-names>G</given-names></name><name name-style="western"><surname>Sihota</surname><given-names>S</given-names></name><name name-style="western"><surname>Rickinson</surname><given-names>AB</given-names></name><name name-style="western"><surname>Young</surname><given-names>LS</given-names></name></person-group><article-title>Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations</article-title><source>Blood</source><year>1996</year><volume>88</volume><fpage>3491</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">8896415</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wohlford</surname><given-names>EM</given-names></name><name name-style="western"><surname>Asito</surname><given-names>AS</given-names></name><name name-style="western"><surname>Chelimo</surname><given-names>K</given-names></name><name name-style="western"><surname>Sumba</surname><given-names>PO</given-names></name><name name-style="western"><surname>Baresel</surname><given-names>PC</given-names></name><name name-style="western"><surname>Oot</surname><given-names>RA</given-names></name><name name-style="western"><surname>Moormann</surname><given-names>AM</given-names></name><name name-style="western"><surname>Rochford</surname><given-names>R</given-names></name></person-group><article-title>Identification of a novel variant of LMP-1 of EBV in patients with endemic Burkitt lymphoma in western Kenya</article-title><source>Infect Agent Cancer</source><year>2013</year><volume>8</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/1750-9378-8-34</pub-id><pub-id pub-id-type="pmid">24016332</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halliburton</surname><given-names>IW</given-names></name></person-group><article-title>Intertypic recombinants of herpes simplex viruses</article-title><source>J Gen Virol</source><year>1980</year><volume>48</volume><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-48-1-1</pub-id><pub-id pub-id-type="pmid">6247430</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eyheramendy</surname><given-names>S</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>FI</given-names></name><name name-style="western"><surname>Manevy</surname><given-names>F</given-names></name><name name-style="western"><surname>Vial</surname><given-names>C</given-names></name><name name-style="western"><surname>Repetto</surname><given-names>GM</given-names></name></person-group><article-title>Genetic structure characterization of Chileans reflects historical immigration patterns</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><fpage>6472</fpage><pub-id pub-id-type="doi">10.1038/ncomms7472</pub-id><pub-id pub-id-type="pmid">25778948</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kodaman</surname><given-names>N</given-names></name><name name-style="western"><surname>Sobota</surname><given-names>RS</given-names></name><name name-style="western"><surname>Mera</surname><given-names>R</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>BG</given-names></name><name name-style="western"><surname>Williams</surname><given-names>SM</given-names></name></person-group><article-title>Disrupted human&#x02013;pathogen co-evolution: a model for disease</article-title><source>Front Genet</source><year>2014</year><fpage>5</fpage><pub-id pub-id-type="pmid">24523726</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Sablet</surname><given-names>T</given-names></name><name name-style="western"><surname>Piazuelo</surname><given-names>MB</given-names></name><name name-style="western"><surname>Shaffer</surname><given-names>CL</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>BG</given-names></name><name name-style="western"><surname>Asim</surname><given-names>M</given-names></name><name name-style="western"><surname>Chaturvedi</surname><given-names>R</given-names></name><name name-style="western"><surname>Bravo</surname><given-names>LE</given-names></name><name name-style="western"><surname>Sicinschi</surname><given-names>LA</given-names></name><name name-style="western"><surname>Delgado</surname><given-names>AG</given-names></name><name name-style="western"><surname>Mera</surname><given-names>RM</given-names></name><name name-style="western"><surname>Israel</surname><given-names>DA</given-names></name><name name-style="western"><surname>Romero-Gallo</surname><given-names>J</given-names></name><name name-style="western"><surname>Peek</surname><given-names>RM</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk</article-title><source>Gut</source><year>2011</year><volume>60</volume><fpage>1189</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1136/gut.2010.234468</pub-id><pub-id pub-id-type="pmid">21357593</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>IS</given-names></name><name name-style="western"><surname>Park</surname><given-names>YS</given-names></name><name name-style="western"><surname>Ho</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>D</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>JY</given-names></name><name name-style="western"><surname>Yook</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>BS</given-names></name></person-group><article-title>Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis</article-title><source>Ann Surg Oncol</source><year>2016</year><volume>23</volume><fpage>3684</fpage><lpage>3692</lpage><pub-id pub-id-type="doi">10.1245/s10434-016-5284-2</pub-id><pub-id pub-id-type="pmid">27221363</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKenzie</surname><given-names>J</given-names></name><name name-style="western"><surname>El-Guindy</surname><given-names>A</given-names></name></person-group><article-title>Epstein-Barr Virus Lytic Cycle Reactivation</article-title><source>Curr Top Microbiol Immunol</source><year>2015</year><volume>391</volume><fpage>237</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-22834-1_8</pub-id><pub-id pub-id-type="pmid">26428377</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>N</given-names></name><name name-style="western"><surname>M Bode</surname><given-names>A</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name></person-group><article-title>Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis</article-title><source>Int J Biol Sci</source><year>2016</year><volume>12</volume><fpage>1309</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.7150/ijbs.16564</pub-id><pub-id pub-id-type="pmid">27877083</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iwakiri</surname><given-names>D</given-names></name><name name-style="western"><surname>Takada</surname><given-names>K</given-names></name></person-group><article-title>Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><fpage>1561</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14734735</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications</article-title><source>World J Virol</source><year>2012</year><volume>1</volume><fpage>154</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.5501/wjv.v1.i6.154</pub-id><pub-id pub-id-type="pmid">24175221</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>HY</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>XX</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JN</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YW</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xue</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>HG</given-names></name><name name-style="western"><surname>Du</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>XY</given-names></name><name name-style="western"><surname>Shao</surname><given-names>CK</given-names></name></person-group><article-title>Expression and prognostic roles of PIK3CA, JAK2, PD-L1 and PD-L2 in EBV-associated gastric carcinoma</article-title><source>Hum Pathol</source><year>2016</year><volume>53</volume><fpage>25</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.humpath.2016.02.007</pub-id><pub-id pub-id-type="pmid">26980034</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plimack</surname><given-names>ER</given-names></name><name name-style="western"><surname>Lorusso</surname><given-names>PM</given-names></name><name name-style="western"><surname>McCoon</surname><given-names>P</given-names></name><name name-style="western"><surname>Tang</surname><given-names>W</given-names></name><name name-style="western"><surname>Krebs</surname><given-names>AD</given-names></name><name name-style="western"><surname>Curt</surname><given-names>G</given-names></name><name name-style="western"><surname>Eckhardt</surname><given-names>SG</given-names></name></person-group><article-title>AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors</article-title><source>Oncologist</source><year>2013</year><volume>18</volume><fpage>819</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.2013-0198</pub-id><pub-id pub-id-type="pmid">23847256</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yao</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Xue</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Si</surname><given-names>J</given-names></name></person-group><article-title>Involvement of nuclear JAK2 signaling in AG490-induced apoptosis of gastric cancer cells</article-title><source>Anat Rec (Hoboken)</source><year>2013</year><volume>296</volume><fpage>1865</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1002/ar.22820</pub-id><pub-id pub-id-type="pmid">24151255</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Judd</surname><given-names>LM</given-names></name><name name-style="western"><surname>Menheniott</surname><given-names>TR</given-names></name><name name-style="western"><surname>Ling</surname><given-names>H</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>CB</given-names></name><name name-style="western"><surname>Howlett</surname><given-names>M</given-names></name><name name-style="western"><surname>Kalantzis</surname><given-names>A</given-names></name><name name-style="western"><surname>Priebe</surname><given-names>W</given-names></name><name name-style="western"><surname>Giraud</surname><given-names>AS</given-names></name></person-group><article-title>Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e95993</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0095993</pub-id><pub-id pub-id-type="pmid">24804649</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boger</surname><given-names>C</given-names></name><name name-style="western"><surname>Behrens</surname><given-names>HM</given-names></name><name name-style="western"><surname>Mathiak</surname><given-names>M</given-names></name><name name-style="western"><surname>Kruger</surname><given-names>S</given-names></name><name name-style="western"><surname>Kalthoff</surname><given-names>H</given-names></name><name name-style="western"><surname>Rocken</surname><given-names>C</given-names></name></person-group><article-title>PD-L1 is an independent prognostic predictor in gastric cancer of Western patients</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>24269</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.8169</pub-id><pub-id pub-id-type="pmid">27009855</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Hong</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>N</given-names></name><name name-style="western"><surname>Qin</surname><given-names>T</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>T</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Liang</surname><given-names>W</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy</article-title><source>Oncotarget</source><year>2014</year><volume>5</volume><fpage>12189</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.2608</pub-id><pub-id pub-id-type="pmid">25361008</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zouridis</surname><given-names>H</given-names></name><name name-style="western"><surname>Deng</surname><given-names>N</given-names></name><name name-style="western"><surname>Ivanova</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wong</surname><given-names>B</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D</given-names></name><name name-style="western"><surname>Wu</surname><given-names>YH</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tan</surname><given-names>IB</given-names></name><name name-style="western"><surname>Liem</surname><given-names>N</given-names></name><name name-style="western"><surname>Gopalakrishnan</surname><given-names>V</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Methylation subtypes and large-scale epigenetic alterations in gastric cancer</article-title><source>Sci Transl Med</source><year>2012</year><volume>4</volume><fpage>156ra40</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.3004504</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loh</surname><given-names>M</given-names></name><name name-style="western"><surname>Liem</surname><given-names>N</given-names></name><name name-style="western"><surname>Vaithilingam</surname><given-names>A</given-names></name><name name-style="western"><surname>Lim</surname><given-names>PL</given-names></name><name name-style="western"><surname>Sapari</surname><given-names>NS</given-names></name><name name-style="western"><surname>Elahi</surname><given-names>E</given-names></name><name name-style="western"><surname>Mok</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>CL</given-names></name><name name-style="western"><surname>Yan</surname><given-names>B</given-names></name><name name-style="western"><surname>Pang</surname><given-names>B</given-names></name><name name-style="western"><surname>Salto-Tellez</surname><given-names>M</given-names></name><name name-style="western"><surname>Yong</surname><given-names>WP</given-names></name><name name-style="western"><surname>Iacopetta</surname><given-names>B</given-names></name><etal/></person-group><article-title>DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach</article-title><source>BMC Gastroenterol</source><year>2014</year><volume>14</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.1186/1471-230X-14-55</pub-id><pub-id pub-id-type="pmid">24674026</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>JL</given-names></name><name name-style="western"><surname>Jones</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Kenney</surname><given-names>SC</given-names></name><name name-style="western"><surname>Rivenbark</surname><given-names>AG</given-names></name><name name-style="western"><surname>Tang</surname><given-names>W</given-names></name><name name-style="western"><surname>Knight</surname><given-names>ER</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>WB</given-names></name><name name-style="western"><surname>Gulley</surname><given-names>ML</given-names></name></person-group><article-title>Epstein-Barr virus-specific methylation of human genes in gastric cancer cells</article-title><source>Infect Agent Cancer</source><year>2010</year><volume>5</volume><fpage>27</fpage><pub-id pub-id-type="doi">10.1186/1750-9378-5-27</pub-id><pub-id pub-id-type="pmid">21194482</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrasi</surname><given-names>AC</given-names></name><name name-style="western"><surname>Pinheiro</surname><given-names>NA</given-names></name><name name-style="western"><surname>Rabenhorst</surname><given-names>SH</given-names></name><name name-style="western"><surname>Caballero</surname><given-names>OL</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>MA</given-names></name><name name-style="western"><surname>de Carvalho</surname><given-names>F</given-names></name><name name-style="western"><surname>Leite</surname><given-names>CV</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>MV</given-names></name><name name-style="western"><surname>Barros</surname><given-names>MA</given-names></name><name name-style="western"><surname>Pardini</surname><given-names>MI</given-names></name></person-group><article-title>Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability</article-title><source>World J Gastroenterol</source><year>2010</year><volume>16</volume><fpage>312</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20082476</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernal</surname><given-names>C</given-names></name><name name-style="western"><surname>Vargas</surname><given-names>M</given-names></name><name name-style="western"><surname>Ossandon</surname><given-names>F</given-names></name><name name-style="western"><surname>Santibanez</surname><given-names>E</given-names></name><name name-style="western"><surname>Urrutia</surname><given-names>J</given-names></name><name name-style="western"><surname>Luengo</surname><given-names>V</given-names></name><name name-style="western"><surname>Zavala</surname><given-names>LF</given-names></name><name name-style="western"><surname>Backhouse</surname><given-names>C</given-names></name><name name-style="western"><surname>Palma</surname><given-names>M</given-names></name><name name-style="western"><surname>Argandona</surname><given-names>J</given-names></name><name name-style="western"><surname>Aguayo</surname><given-names>F</given-names></name><name name-style="western"><surname>Corval&#x000e1;n</surname><given-names>AH</given-names></name></person-group><article-title>DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis</article-title><source>Biol Res</source><year>2008</year><volume>41</volume><fpage>303</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">19399343</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCormick</surname><given-names>TM</given-names></name><name name-style="western"><surname>Canedo</surname><given-names>NH</given-names></name><name name-style="western"><surname>Furtado</surname><given-names>YL</given-names></name><name name-style="western"><surname>Silveira</surname><given-names>FA</given-names></name><name name-style="western"><surname>de Lima</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Rosman</surname><given-names>AD</given-names></name><name name-style="western"><surname>Almeida Filho</surname><given-names>GL</given-names></name><name name-style="western"><surname>Carvalho Mda</surname><given-names>G</given-names></name></person-group><article-title>Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study</article-title><source>Diagn Pathol</source><year>2015</year><volume>10</volume><fpage>59</fpage><pub-id pub-id-type="doi">10.1186/s13000-015-0283-3</pub-id><pub-id pub-id-type="pmid">26032781</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YW</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>NN</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JN</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shao</surname><given-names>CK</given-names></name></person-group><article-title>Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas</article-title><source>Med Oncol</source><year>2015</year><volume>32</volume><fpage>92</fpage><pub-id pub-id-type="doi">10.1007/s12032-015-0525-y</pub-id><pub-id pub-id-type="pmid">25720522</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dang</surname><given-names>S</given-names></name><name name-style="western"><surname>Hou</surname><given-names>P</given-names></name></person-group><article-title>Gene methylation in gastric cancer</article-title><source>Clin Chim Acta</source><year>2013</year><volume>424</volume><fpage>53</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2013.05.002</pub-id><pub-id pub-id-type="pmid">23669186</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campos</surname><given-names>FI</given-names></name><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>S</given-names></name><name name-style="western"><surname>Carrasquilla</surname><given-names>G</given-names></name><name name-style="western"><surname>Serra</surname><given-names>M</given-names></name><name name-style="western"><surname>Carrascal</surname><given-names>E</given-names></name><name name-style="western"><surname>Itoh</surname><given-names>T</given-names></name><name name-style="western"><surname>Minakami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Eizuru</surname><given-names>Y</given-names></name></person-group><article-title>Environmental factors related to gastric cancer associated with Epstein-Barr virus in Colombia</article-title><source>Asian Pac J Cancer Prev</source><year>2006</year><volume>7</volume><fpage>633</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17250442</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>S</given-names></name><name name-style="western"><surname>Minakami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Eizuru</surname><given-names>Y</given-names></name></person-group><article-title>Environmental factors related to Epstein-Barr virus-associated gastric cancer in Japan</article-title><source>J Exp Clin Cancer Res</source><year>2005</year><volume>24</volume><fpage>547</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">16471317</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chabay</surname><given-names>PA</given-names></name><name name-style="western"><surname>Preciado</surname><given-names>MV</given-names></name></person-group><article-title>EBV primary infection in childhood and its relation to B-cell lymphoma development: a mini-review from a developing region</article-title><source>Int J Cancer</source><year>2013</year><volume>133</volume><fpage>1286</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1002/ijc.27858</pub-id><pub-id pub-id-type="pmid">23001576</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campos</surname><given-names>FI</given-names></name><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Akiba</surname><given-names>S</given-names></name><name name-style="western"><surname>Carrasquilla</surname><given-names>G</given-names></name><name name-style="western"><surname>Serra</surname><given-names>M</given-names></name><name name-style="western"><surname>Carrascal</surname><given-names>E</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Nakano</surname><given-names>A</given-names></name></person-group><article-title>Toenail zinc level and gastric cancer risk in Cali, Colombia</article-title><source>J Cancer Res Clin Oncol</source><year>2008</year><volume>134</volume><fpage>169</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1007/s00432-007-0266-1</pub-id><pub-id pub-id-type="pmid">17619905</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>JL</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>DR</given-names></name><name name-style="western"><surname>Dominguez</surname><given-names>RL</given-names></name><name name-style="western"><surname>Thorne</surname><given-names>LB</given-names></name><name name-style="western"><surname>Elmore</surname><given-names>SH</given-names></name><name name-style="western"><surname>Mino-Kenudson</surname><given-names>M</given-names></name><name name-style="western"><surname>Lauwers</surname><given-names>GY</given-names></name><name name-style="western"><surname>Booker</surname><given-names>JK</given-names></name><name name-style="western"><surname>Gulley</surname><given-names>ML</given-names></name></person-group><article-title>High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma</article-title><source>Lab Invest</source><year>2009</year><volume>89</volume><fpage>80</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/labinvest.2008.103</pub-id><pub-id pub-id-type="pmid">19002111</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camargo</surname><given-names>MC</given-names></name><name name-style="western"><surname>Koriyama</surname><given-names>C</given-names></name><name name-style="western"><surname>Matsuo</surname><given-names>K</given-names></name><name name-style="western"><surname>Kim</surname><given-names>WH</given-names></name><name name-style="western"><surname>Herrera-Goepfert</surname><given-names>R</given-names></name><name name-style="western"><surname>Liao</surname><given-names>LM</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Carrasquilla</surname><given-names>G</given-names></name><name name-style="western"><surname>Sung</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Alvarado-Cabrero</surname><given-names>I</given-names></name><name name-style="western"><surname>Lissowska</surname><given-names>J</given-names></name><name name-style="western"><surname>Meneses-Gonzalez</surname><given-names>F</given-names></name><name name-style="western"><surname>Yatabe</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer</article-title><source>Int J Cancer</source><year>2014</year><volume>134</volume><fpage>948</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1002/ijc.28402</pub-id><pub-id pub-id-type="pmid">23904115</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eom</surname><given-names>SY</given-names></name><name name-style="western"><surname>Yim</surname><given-names>DH</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yun</surname><given-names>JK</given-names></name><name name-style="western"><surname>Moon</surname><given-names>SI</given-names></name><name name-style="western"><surname>Yun</surname><given-names>HY</given-names></name><name name-style="western"><surname>Song</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Youn</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Hyun</surname><given-names>T</given-names></name><name name-style="western"><surname>Park</surname><given-names>JS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>BS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YD</given-names></name><etal/></person-group><article-title>Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean</article-title><source>Cancer Causes Control</source><year>2013</year><volume>24</volume><fpage>1963</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s10552-013-0272-3</pub-id><pub-id pub-id-type="pmid">23949201</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Accardi</surname><given-names>R</given-names></name><name name-style="western"><surname>Gruffat</surname><given-names>H</given-names></name><name name-style="western"><surname>Sirand</surname><given-names>C</given-names></name><name name-style="western"><surname>Fusil</surname><given-names>F</given-names></name><name name-style="western"><surname>Gheit</surname><given-names>T</given-names></name><name name-style="western"><surname>Hernandez-Vargas</surname><given-names>H</given-names></name><name name-style="western"><surname>Le Calvez-Kelm</surname><given-names>F</given-names></name><name name-style="western"><surname>Traverse-Glehen</surname><given-names>A</given-names></name><name name-style="western"><surname>Cosset</surname><given-names>FL</given-names></name><name name-style="western"><surname>Manet</surname><given-names>E</given-names></name><name name-style="western"><surname>Wild</surname><given-names>CP</given-names></name><name name-style="western"><surname>Tommasino</surname><given-names>M</given-names></name></person-group><article-title>The mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in <italic>in vitro</italic> and <italic>in vivo</italic> experimental models</article-title><source>Carcinogenesis</source><year>2015</year><volume>36</volume><fpage>1440</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgv142</pub-id><pub-id pub-id-type="pmid">26424750</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandoval-Borquez</surname><given-names>A</given-names></name><name name-style="western"><surname>Saavedra</surname><given-names>K</given-names></name><name name-style="western"><surname>Carrasco-Avino</surname><given-names>G</given-names></name><name name-style="western"><surname>Garcia-Bloj</surname><given-names>B</given-names></name><name name-style="western"><surname>Fry</surname><given-names>J</given-names></name><name name-style="western"><surname>Wichmann</surname><given-names>I</given-names></name><name name-style="western"><surname>Corvalan</surname><given-names>AH</given-names></name></person-group><article-title>Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers</article-title><source>Disease Markers</source><year>2015</year><volume>2015</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.1155/2015/503762</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valenzuela</surname><given-names>MA</given-names></name><name name-style="western"><surname>Canales</surname><given-names>J</given-names></name><name name-style="western"><surname>Corvalan</surname><given-names>AH</given-names></name><name name-style="western"><surname>Quest</surname><given-names>AF</given-names></name></person-group><article-title>Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis</article-title><source>World J Gastroenterol</source><year>2015</year><volume>21</volume><fpage>12742</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.3748/wjg.v21.i45.12742</pub-id><pub-id pub-id-type="pmid">26668499</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camargo</surname><given-names>MC</given-names></name><name name-style="western"><surname>Kim</surname><given-names>KM</given-names></name><name name-style="western"><surname>Matsuo</surname><given-names>K</given-names></name><name name-style="western"><surname>Torres</surname><given-names>J</given-names></name><name name-style="western"><surname>Liao</surname><given-names>LM</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>DR</given-names></name><name name-style="western"><surname>Michel</surname><given-names>A</given-names></name><name name-style="western"><surname>Waterboer</surname><given-names>T</given-names></name><name name-style="western"><surname>Zabaleta</surname><given-names>J</given-names></name><name name-style="western"><surname>Dominguez</surname><given-names>RL</given-names></name><name name-style="western"><surname>Yatabe</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Rocha-Guevara</surname><given-names>ER</given-names></name><etal/></person-group><article-title>Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer</article-title><source>Helicobacter</source><year>2015</year><pub-id pub-id-type="doi">10.1111/hel.12249</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watanabe</surname><given-names>H</given-names></name><name name-style="western"><surname>Enjoji</surname><given-names>M</given-names></name><name name-style="western"><surname>Imai</surname><given-names>T</given-names></name></person-group><article-title>Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations</article-title><source>Cancer</source><year>1976</year><volume>38</volume><fpage>232</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">947518</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burke</surname><given-names>AP</given-names></name><name name-style="western"><surname>Yen</surname><given-names>TS</given-names></name><name name-style="western"><surname>Shekitka</surname><given-names>KM</given-names></name><name name-style="western"><surname>Sobin</surname><given-names>LH</given-names></name></person-group><article-title>Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction</article-title><source>Mod Pathol</source><year>1990</year><volume>3</volume><fpage>377</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">2163534</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>LM</given-names></name><name name-style="western"><surname>Gaffey</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>D</given-names></name></person-group><article-title>Lymphoepithelioma-like carcinoma and its relationship to Epstein-Barr virus</article-title><source>Am J Clin Pathol</source><year>1991</year><volume>96</volume><fpage>156</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1650531</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Min</surname><given-names>KW</given-names></name><name name-style="western"><surname>Holmquist</surname><given-names>S</given-names></name><name name-style="western"><surname>Peiper</surname><given-names>SC</given-names></name><name name-style="western"><surname>O'Leary</surname><given-names>TJ</given-names></name></person-group><article-title>Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelioma-like carcinomas) of the stomach. Report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction</article-title><source>Am J Clin Pathol</source><year>1991</year><volume>96</volume><fpage>219</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">1650533</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathiak</surname><given-names>M</given-names></name><name name-style="western"><surname>Warneke</surname><given-names>VS</given-names></name><name name-style="western"><surname>Behrens</surname><given-names>HM</given-names></name><name name-style="western"><surname>Haag</surname><given-names>J</given-names></name><name name-style="western"><surname>Boger</surname><given-names>C</given-names></name><name name-style="western"><surname>Kruger</surname><given-names>S</given-names></name><name name-style="western"><surname>Rocken</surname><given-names>C</given-names></name></person-group><article-title>Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization</article-title><source>Appl Immunohistochem Mol Morphol</source><year>2017</year><volume>25</volume><fpage>12</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1097/pai.0000000000000264</pub-id><pub-id pub-id-type="pmid">26371427</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>H</given-names></name><name name-style="western"><surname>Park</surname><given-names>YS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Son</surname><given-names>DH</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>JY</given-names></name><name name-style="western"><surname>Choi</surname><given-names>KS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>KD</given-names></name><name name-style="western"><surname>Song</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>GH</given-names></name><name name-style="western"><surname>Jung</surname><given-names>HY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Yook</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus</article-title><source>Clin Gastroenterol Hepatol</source><year>2015</year><volume>13</volume><fpage>1738</fpage><lpage>44 e2</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2015.04.015</pub-id><pub-id pub-id-type="pmid">25912839</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>N</given-names></name><name name-style="western"><surname>Hui</surname><given-names>DY</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>NN</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Han</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>HG</given-names></name><name name-style="western"><surname>Ding</surname><given-names>YG</given-names></name><name name-style="western"><surname>Du</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JN</given-names></name><name name-style="western"><surname>Shao</surname><given-names>CK</given-names></name></person-group><article-title>Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms</article-title><source>Gastric Cancer</source><year>2015</year><volume>18</volume><fpage>246</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1007/s10120-014-0376-9</pub-id><pub-id pub-id-type="pmid">24771002</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gutierrez</surname><given-names>MI</given-names></name><name name-style="western"><surname>Raj</surname><given-names>A</given-names></name><name name-style="western"><surname>Spangler</surname><given-names>G</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>A</given-names></name><name name-style="western"><surname>Judde</surname><given-names>JG</given-names></name><name name-style="western"><surname>Tsao</surname><given-names>SW</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>PW</given-names></name><name name-style="western"><surname>Joab</surname><given-names>I</given-names></name><name name-style="western"><surname>Magrath</surname><given-names>IT</given-names></name><name name-style="western"><surname>Bhatia</surname><given-names>K</given-names></name></person-group><article-title>Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells</article-title><source>J Gen Virol</source><year>1997</year><volume>7</volume><fpage>1663</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-78-7-1663</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="book"><person-group person-group-type="editor"><name name-style="western"><surname>Forman</surname><given-names>D</given-names></name><name name-style="western"><surname>Bray</surname><given-names>F</given-names></name><name name-style="western"><surname>Brewster</surname><given-names>DH</given-names></name><name name-style="western"><surname>Gombe Mbalawa</surname><given-names>C</given-names></name><name name-style="western"><surname>Kohler</surname><given-names>B</given-names></name><name name-style="western"><surname>Pi&#x000f1;eros</surname><given-names>M</given-names></name><name name-style="western"><surname>Steliarova-Foucher</surname><given-names>E</given-names></name><name name-style="western"><surname>Swaminathan</surname><given-names>R</given-names></name><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name></person-group><comment>(2013) Cancer Incidence in Five Continents, Vol. X (electronic version). Lyon: International Agency for Research on Cancer. Available from: <ext-link ext-link-type="uri" xlink:href="http://ci5.iarc.fr">http://ci5.iarc.fr</ext-link>. accessed 2017-05-24</comment></element-citation></ref></ref-list></back></article>